Compositions and methods for treatment of autoimmune and allergic diseases

Details for Australian Patent Application No. 2008339093 (hide)

Owner MIVAC Development Aktiebolag

Inventors Lycke, Nils

Agent Davies Collison Cave

Pub. Number AU-A-2008339093

PCT Pub. Number WO2009/078796

Priority 0702825-1 19.12.07 SE

Filing date 15 December 2008

Wipo publication date 25 June 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/078796 Priority application(s): WO2009/078796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008339095-Pharmaceutically acceptable salts of methyl (3-{ [[3-(6amino2-butoxy-8-oxo-7, 8-dihydro-9H-purin-9-yl) propyl] (3morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy

2008339091-Compounds for use in the treatment of cancer